Adjuvant Fuzheng Huayu Capsule Reduces the Incidence of Hepatocellular Carcinoma in Patients with Hepatitis B-Caused Cirrhosis

Figure 3

Subgroup analyses of the risk of HCC according to the THRI score and Child-Pugh classification. (a) Low-risk patients; (b) Medium-risk patients; (c) High-risk patients; (d) Child-Pugh A patients; (e) Child-Pugh B patients; (f) Child-Pugh C patients. HCC: hepatocellular carcinoma; THRI: Toronto HCC risk index.

(a)

(b)

(c)

(d)

(e)

(f)